-
-
-
-
-
-
-
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
-
-
-
-
-
-
-
Denali Capital Acquisition Corp (DECA) Announces Extension of Deadline to Complete Business Combination
-
-
-
-
-
-
-
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
-
-
-
-
-
-
-
Form 425 Denali Capital Acquisiti Filed by: Denali Capital Acquisition Corp.
-
-
-
-
-
-
-
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Co
-
-
-
-
-
-
-
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
-
-
-
-
-
-
-
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

